An investigation into the molecular mechanisms underlying retinitis pigmentosa 17 with the view to developing novel gene- based therapies

Simple item page
dc.contributor.authorPandor, Aishaen_ZA
dc.date.accessioned2015-10-30T10:45:38Z
dc.date.available2015-10-30T10:45:38Z
dc.date.issued2012en_ZA
dc.descriptionIncludes bibliographical references.en_ZA
dc.description.abstractRetinitis pigmentosa (RP) is a highly heterogeneous form of inherited blindness that affects more than 1.3 million individuals worldwide. The RP17 form of the disease is caused by an arginine to tryptophan (R14W) mutation in the signal sequence of carbonic anhydrase IV (CAIV). In an effort to elucidate the molecular mechanisms underlying RP17, three cell types were transfected with the wild type (WT ) and the R14W mutant form of the protein. We show using immunocytochemistry that unlike transfected WT CAIV which is transported to the plasma membrane of transfected COS-7 and HT-1080 cells, R14W mutant CAIV is retained in the endoplasmic reticulum when transfected into the same cell type. Further analyses of these cells by western blotting reveal that whereas the WT CAIV is processed to its mature form in both these cell lines, significant levels of the R14W mutant protein remain in its immature form. Importantly, flow cytometry experiments demonstrate that compared to WT CAIV protein, expression of specifically the R14W CAIV results in an S and G2/M cell cycle block, followed by apoptosis. Interestingly, when the above experiments were repeated in the human embryonic kidney cell line, HEK-293, strikingly different results were obtained. These cells were unaffected by the expression of the R14W mutant CAIV and were able to process the mutant and WT protein equally effectively. These findings regarding cell type specificity were used as a basis to explore methods of therapy for RP17. In particular, allele-specific small hairpin RNA was used to silence expression of R14W mutant CAIV, and to rescue cells from undergoing cell cycle arrest and apoptosis. A study of specific chaperones involved in protein folding, as well as gene and protein expression studies (microarray and mass spectrometry analysis), were also carried out to determine which proteins that were expressed in HEK-293 cells play a part in the ability to fold, process and transport R14W mutant CAIV. The results of this study have important implications for our understanding of the RP17 phenotype, and in investigating gene and protein therapy for the prevention and treatment of RP17.en_ZA
dc.identifier.apacitationPandor, A. (2012). <i>An investigation into the molecular mechanisms underlying retinitis pigmentosa 17 with the view to developing novel gene- based therapies</i>. (Thesis). University of Cape Town ,Faculty of Health Sciences ,Department of Clinical Laboratory Sciences. Retrieved from http://hdl.handle.net/11427/14566en_ZA
dc.identifier.chicagocitationPandor, Aisha. <i>"An investigation into the molecular mechanisms underlying retinitis pigmentosa 17 with the view to developing novel gene- based therapies."</i> Thesis., University of Cape Town ,Faculty of Health Sciences ,Department of Clinical Laboratory Sciences, 2012. http://hdl.handle.net/11427/14566en_ZA
dc.identifier.citationPandor, A. 2012. An investigation into the molecular mechanisms underlying retinitis pigmentosa 17 with the view to developing novel gene- based therapies. University of Cape Town.en_ZA
dc.identifier.ris TY - Thesis / Dissertation AU - Pandor, Aisha AB - Retinitis pigmentosa (RP) is a highly heterogeneous form of inherited blindness that affects more than 1.3 million individuals worldwide. The RP17 form of the disease is caused by an arginine to tryptophan (R14W) mutation in the signal sequence of carbonic anhydrase IV (CAIV). In an effort to elucidate the molecular mechanisms underlying RP17, three cell types were transfected with the wild type (WT ) and the R14W mutant form of the protein. We show using immunocytochemistry that unlike transfected WT CAIV which is transported to the plasma membrane of transfected COS-7 and HT-1080 cells, R14W mutant CAIV is retained in the endoplasmic reticulum when transfected into the same cell type. Further analyses of these cells by western blotting reveal that whereas the WT CAIV is processed to its mature form in both these cell lines, significant levels of the R14W mutant protein remain in its immature form. Importantly, flow cytometry experiments demonstrate that compared to WT CAIV protein, expression of specifically the R14W CAIV results in an S and G2/M cell cycle block, followed by apoptosis. Interestingly, when the above experiments were repeated in the human embryonic kidney cell line, HEK-293, strikingly different results were obtained. These cells were unaffected by the expression of the R14W mutant CAIV and were able to process the mutant and WT protein equally effectively. These findings regarding cell type specificity were used as a basis to explore methods of therapy for RP17. In particular, allele-specific small hairpin RNA was used to silence expression of R14W mutant CAIV, and to rescue cells from undergoing cell cycle arrest and apoptosis. A study of specific chaperones involved in protein folding, as well as gene and protein expression studies (microarray and mass spectrometry analysis), were also carried out to determine which proteins that were expressed in HEK-293 cells play a part in the ability to fold, process and transport R14W mutant CAIV. The results of this study have important implications for our understanding of the RP17 phenotype, and in investigating gene and protein therapy for the prevention and treatment of RP17. DA - 2012 DB - OpenUCT DP - University of Cape Town LK - https://open.uct.ac.za PB - University of Cape Town PY - 2012 T1 - An investigation into the molecular mechanisms underlying retinitis pigmentosa 17 with the view to developing novel gene- based therapies TI - An investigation into the molecular mechanisms underlying retinitis pigmentosa 17 with the view to developing novel gene- based therapies UR - http://hdl.handle.net/11427/14566 ER - en_ZA
dc.identifier.urihttp://hdl.handle.net/11427/14566
dc.identifier.vancouvercitationPandor A. An investigation into the molecular mechanisms underlying retinitis pigmentosa 17 with the view to developing novel gene- based therapies. [Thesis]. University of Cape Town ,Faculty of Health Sciences ,Department of Clinical Laboratory Sciences, 2012 [cited yyyy month dd]. Available from: http://hdl.handle.net/11427/14566en_ZA
dc.language.isoengen_ZA
dc.publisher.departmentDepartment of Clinical Laboratory Sciencesen_ZA
dc.publisher.facultyFaculty of Health Sciencesen_ZA
dc.publisher.institutionUniversity of Cape Town
dc.subject.otherHuman Geneticsen_ZA
dc.subject.otherRetinitis pigmentosaen_ZA
dc.titleAn investigation into the molecular mechanisms underlying retinitis pigmentosa 17 with the view to developing novel gene- based therapiesen_ZA
dc.typeDoctoral Thesis
dc.type.qualificationlevelDoctoral
dc.type.qualificationnamePhDen_ZA
uct.type.filetypeText
uct.type.filetypeImage
uct.type.publicationResearchen_ZA
uct.type.resourceThesisen_ZA
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
thesis_hsf_2012_pandor_aisha.pdf
Size:
7.93 MB
Format:
Adobe Portable Document Format
Description:
Download
Collections
PhD / Doctoral